Cargando…
Reactivation of HIC-1 gene by saRNA inhibits clonogenicity and invasiveness in breast cancer cells
Hypermethylated in cancer 1 (HIC-1) is a tumor suppressor gene, which is epigenetically silenced in breast cancer. It is known that the loss of HIC-1, caused by promoter hypermethylation, is associated with tumor aggression and poor survival in breast carcinoma. It has been shown that small activati...
Autores principales: | ZHAO, FENG, PAN, SHENGLI, GU, YAN, GUO, SHANYU, DAI, QIANCHENG, YU, YINGYAN, ZHANG, WEI |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246611/ https://www.ncbi.nlm.nih.gov/pubmed/25435951 http://dx.doi.org/10.3892/ol.2014.2633 |
Ejemplares similares
-
Small Activating RNA Restores the Activity of the Tumor Suppressor HIC-1 on Breast Cancer
por: Zhao, Feng, et al.
Publicado: (2014) -
Gene activation of CEBPA using saRNA: Preclinical studies of the first in human saRNA drug candidate for liver cancer
por: Reebye, Vikash, et al.
Publicado: (2018) -
The evaluation of novel oral vaccines based on self-amplifying RNA lipid nanparticles (saRNA LNPs), saRNA transfected Lactobacillus plantarum LNPs, and saRNA transfected Lactobacillus plantarum to neutralize SARS-CoV-2 variants alpha and delta
por: Keikha, Reza, et al.
Publicado: (2021) -
Advances in saRNA Vaccine Research against Emerging/Re-Emerging Viruses
por: Liu, Yalan, et al.
Publicado: (2023) -
Poly(2-oxazoline)/saRNA
Polyplexes for Targeted and
Nonviral Gene Delivery
por: Hayes, Graham, et al.
Publicado: (2023)